Overview
Scribe Therapeutics develops CRISPR-based gene editing therapies for inherited diseases through targeted in vivo genome modification.
More in Research Tools
Latest industry news
Guardant Health's FDA-Cleared Genomic-Epigenomic Liquid Biopsy Panel Marks a Turning Point for Cancer Detection
2026-10-14 · Product
Ambry Genetics Launches GenomeNext™ Whole Genome Sequencing Solution to Close the Rare Disease Diagnosis Gap
2026-10-13 · Product
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
Company details
Category
🔭 Research Tools
Location
Alameda, California, United States
Funding
$165,000,000
Website
scribetx.comListed
2026-06-23
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →